Keith A. Kucinski
Overview
Keith A. Kucinski received $627K in total compensation, including $249K in salary, at Matinas BioPharma Holdings in 2019.
Source: SEC filing on October 1, 2020.
Related executives
We found nine more executives who work or worked at Matinas BioPharma Holdings.
Jerome Jabbour
Matinas BioPharma Holdings
Chief Executive Officer
James Ferguson
Matinas BioPharma Holdings
Chief Medical Officer
Theresa Matkovits
Matinas BioPharma Holdings
Chief Development Officer
Roelof Rongen
Matinas BioPharma Holdings
Chief Executive Officer
Raphael Mannino
Matinas BioPharma Holdings
Chief Scientific Officer
Gary Gaglione
Matinas BioPharma Holdings
Chief Financial Officer
Dominick DiPaolo
Matinas BioPharma Holdings
Former Senior Vice President, Quality and Regulatory Compliance
Douglas Kling
Matinas BioPharma Holdings